0001628280-22-032519 Sample Contracts

GRI BIO, INC. WARRANT TO PURCHASE COMMON STOCK
Vallon Pharmaceuticals, Inc. • December 23rd, 2022 • Pharmaceutical preparations • Delaware

THIS CERTIFIES THAT, for value received, FT618 Investments, LLC (the “Holder”), is entitled to subscribe for and purchase from GRI Bio, Inc., a Delaware corporation (the “Company”), the Exercise Shares at the Exercise Price (each subject to adjustment as provided herein).

Sample 1Sample 2Sample 3See All (5)
AutoNDA by SimpleDocs
STANDARD OFFICE LEASE LA JOLLA SHORES PLAZA
Office Lease • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS STANDARD OFFICE LEASE (“Lease”) is entered into effective as of March 2, 2018 (“Effective Date”), between LA JOLLA SHORES PLAZA, LLC, a California limited liability company (“Landlord”), and GRI BIO, INC., a Delaware Corporation (“Tenant”). Landlord and Tenant agree as follows:

Sample 1Sample 2Sample 3See All (4)
GLYCOREGIMMUNE, INC. RESTRICTED STOCK PURCHASE AGREEMENT Walter Marc Hertz
Restricted Stock Purchase Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • California

THIS RESTRICTED STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of March 28, 2009 by and between Glycoregimmune, Inc., a Delaware corporation (the “Company”), and W. Marc Hertz, an individual (the “Purchaser”).

Sample 1Sample 2Sample 3
GRI BIO, INC. NONQUALIFIED STOCK OPTION AGREEMENT Signature Page
Nonqualified Stock Option Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

GRI Bio, Inc., a Delaware corporation (the “Company”), hereby grants to you (the “Optionee”) the following option (the “Option”) to purchase shares of Common Stock, par value $0.01 per share (“Common Stock”), of the Company:

Sample 1Sample 2
STOCK REDEMPTION AGREEMENT
Stock Redemption Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

This Stock Redemption Agreement (this “Agreement”) is entered into as of the 2nd day of November, 2018 (the “Effective Date”), by and between GRI Bio, Inc., a Delaware corporation located at 2223 Avenida de la Playa, #208, La Jolla, CA 92037 (the “Company”), and Catalent Ontario Limited, an Ontario company, with an office located at 2125 Ambassador Drive, Ontario N9C 3R5, Canada (the “Stockholder”).

Sample 1
CONSULTING AND SCIENTIFIC ADVISORY BOARD AGREEMENT
Consulting and Scientific Advisory Board Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS CONSULTING AGREEMENT effective as of October 31, 2018 (the “Effective Date”), is between GRI Bio, Inc. (the “Company”), and Vipin Kumar Chaturvedi personally or through Vidur Discoveries LLC (the “Consultant”).

Sample 1
CONSULTING AND CLINICAL ADVISORY BOARD AGREEMENT
Consulting and Clinical Advisory Board Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS CONSULTING AGREEMENT effective as of June 3, 2016 (the “Effective Date”), is between GRI Bio, Inc. (the “Company”), and Rohit Loomba, M.D. (the “Consultant”).

Sample 1
GRI BIO, INC. INCENTIVE STOCK OPTION AGREEMENT Signature Page
Incentive Stock Option Agreement • December 23rd, 2022 • Vallon Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

GRI Bio, Inc., a Delaware corporation (the “Company”), hereby grants to you (the “Optionee”) the following option (the “Option”) to purchase shares of Common Stock, par value $0.01 per share (“Common Stock”), of the Company:

Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.